Labcorp Files 8-K on Shareholder Votes
Ticker: LH · Form: 8-K · Filed: May 16, 2024 · CIK: 920148
| Field | Detail |
|---|---|
| Company | Laboratory Corp Of America Holdings (LH) |
| Form Type | 8-K |
| Filed Date | May 16, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.10 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, disclosure
TL;DR
Labcorp filed an 8-K about shareholder votes. Nothing major to see here yet.
AI Summary
Laboratory Corporation of America Holdings filed an 8-K on May 16, 2024, reporting on matters submitted to a vote of security holders. The filing date indicates the report was submitted on May 16, 2024, with the earliest event reported being May 14, 2024. The company, incorporated in Delaware, is headquartered in Burlington, North Carolina.
Why It Matters
This filing indicates that Laboratory Corporation of America Holdings is providing updates or disclosures regarding decisions made by its shareholders, which can impact corporate governance and future strategic directions.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of matters submitted to a vote of security holders and does not appear to contain any immediate negative financial or operational news.
Key Players & Entities
- Laboratory Corporation of America Holdings (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- Burlington, North Carolina (location) — Principal executive offices
- May 14, 2024 (date) — Date of earliest event reported
- May 16, 2024 (date) — Filing date
FAQ
What specific matters were submitted to a vote of Laboratory Corporation of America Holdings' security holders?
The filing does not specify the exact matters submitted to a vote, only that it is a report on such submissions.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on May 14, 2024.
What is the principal executive office address for Laboratory Corporation of America Holdings?
The principal executive offices are located at 358 South Main Street, Burlington, North Carolina 27215.
Under which section of the Securities Exchange Act of 1934 is this 8-K filed?
This 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the SIC code for Laboratory Corporation of America Holdings?
The Standard Industrial Classification (SIC) code is 8071, which corresponds to Medical Laboratories.
Filing Stats: 838 words · 3 min read · ~3 pages · Grade level 10.7 · Accepted 2024-05-16 16:19:50
Key Financial Figures
- $0.10 — nge on which registered Common Stock , $0.10 par value LH New York Stock Exchange
Filing Documents
- lh-20240514.htm (8-K) — 52KB
- 0000920148-24-000036.txt ( ) — 176KB
- lh-20240514.xsd (EX-101.SCH) — 2KB
- lh-20240514_lab.xml (EX-101.LAB) — 22KB
- lh-20240514_pre.xml (EX-101.PRE) — 12KB
- lh-20240514_htm.xml (XML) — 3KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders The 2024 Annual Meeting of Shareholders (the "Annual Meeting") of Laboratory Corporation of America Holdings (the "Company") was held on May 14, 2024. As of March 20, 2024, the date of record for determining the Company's shareholders entitled to vote on the proposals presented at the Annual Meeting, there were 84,125,885 shares of the Company's common stock issued and outstanding and entitled to vote at the Annual Meeting. The holders of 77,058,074 shares of the Company's issued and outstanding common stock were represented in person or by proxy at the Annual Meeting, constituting a quorum. The proposals presented at the Annual Meeting are described in detail in the Company's definitive proxy statement filed with the Securities and Exchange Commission on April 4, 2024 (the "Proxy Statement"). The vote results detailed below represent final results as certified by the Inspector of Elections. Proposal 1. The Company's shareholders elected the following persons, who were listed in the Proxy Statement, to the Board of Directors of the Company (the "Board") to hold office for the term expiring at the 2025 Annual Meeting of Shareholders or until their successors are elected and qualified or until their earlier death, resignation, or removal: Votes For Votes Against Abstentions Broker Non-Votes Adam H. Schechter 66,696,331 3,866,647 240,211 6,254,885 Kerrii B. Anderson 65,317,209 5,379,339 106,641 6,254,885 Jeffrey A. Davis 70,603,583 89,968 109,638 6,254,885 D. Gary Gilliland, M.D., Ph.D. 70,026,112 666,813 110,264 6,254,885 Kirsten M. Kliphouse 70,637,639 59,699 105,851 6,254,885 Garheng Kong, M.D., Ph.D. 68,880,113 1,816,173 106,903 6,254,885 Peter M. Neupert 67,187,525 3,507,269 108,395 6,254,885 Richelle P. Parham 68,403,353 2,291,498 108,338 6,254,885 Paul B. Rothman, M.D. 70,622,022 73,434 107,733 6,254,885 Kathryn E. Wengel 45,457,646 25,179,174 166,369 6,254,885 Propos
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LABORATORY CORPORATION OF AMERICA HOLDINGS Registrant By: /s/ SANDRA VAN DER VAART Sandra van der Vaart Executive Vice President, Chief Legal Officer and Corporate Secretary May 16, 2024